MedTrace Logo

Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma

NCT00672321 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2774

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Gathering information about vitamin D supplementation and sun exposure in patients with melanoma may help doctors learn more about the disease and find what may affect cancer relapse.

PURPOSE: This clinical trial is studying vitamin D supplementation and sun exposure in patients who have undergone surgery for stage IB, stage II, or stage IIIA melanoma.

Conditions

  • Melanoma (Skin)

Interventions

GENETIC

gene expression analysis

GENETIC

mutation analysis

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

OTHER

questionnaire administration

Sponsors & Collaborators

  • Leeds Cancer Centre at St. James's University Hospital

    lead OTHER

Principal Investigators

  • Julia Newton Bishop, MD · Leeds Cancer Centre at St. James's University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2010-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00672321 on ClinicalTrials.gov